FDA Guidance on Diversity in Clinical Research
FDA Guidance on Diversity in Clinical Research Understanding the FDA’s Guidance on Diversity in Clinical Research In recent years, the U.S. Food and Drug Administration (FDA) has taken bold steps to improve diversity in clinical trials. The lack of adequate representation of racial, ethnic, and other demographic groups has long hindered the generalizability and ethical…
Read More “FDA Guidance on Diversity in Clinical Research” »
